- Conditions
- Chronic Prostatitis, Chronic Pelvic Pain Syndrome
- Interventions
- AQX-1125 200 mg, Placebo
- Drug
- Lead sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
- Industry
- Eligibility
- 18 Years to 80 Years · Male only
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 23
- States / cities
- Homewood, Alabama • Mobile, Alabama • Tucson, Arizona + 19 more
Source: ClinicalTrials.gov public record
Updated Jan 8, 2019 · Synced May 21, 2026, 6:16 PM EDT